What Is the Breast Cancer Vaccine?
Breast cancer vaccines, vaccines to prevent breast cancer vaccination, can prevent breast cancer like influenza vaccines. A well-known cancer expert pointed out that the cause of breast cancer is fully grasped, and the birth of vaccines or preventive products is just around the corner.
Breast cancer vaccine
- This entry lacks an overview map . Supplementing related content makes the entry more complete and can be upgraded quickly. Come on!
- Chinese name
- Breast cancer vaccine
- Foreign name
- Breast cancer vaccine
- Function
- Prevent breast cancer
- On behalf of
- Synthetic polysaccharide vaccine
- Breast cancer vaccines, vaccines to prevent breast cancer vaccination, can prevent breast cancer like influenza vaccines. A well-known cancer expert pointed out that the cause of breast cancer is fully grasped, and the birth of vaccines or preventive products is just around the corner.
- Breast cancer vaccine is just around the corner
- Breast cancer has the highest risk of cancer in women
- Anti-cancer vaccine can activate
Breast cancer vaccine
- In 2006, Danish breast cancer vaccines produced by Pharmexa Biotech began testing in the UK and Denmark. Dana Leach, the company's manager of clinical development and immunopharmacology, told the 3rd European Breast Cancer Conference (approximately 4,000 scientists, doctors and patients) that the self-resting vaccine attacked HER- 2 protein (the protein is overexpressed in many tumors). It boosts women's immune response, produces killer T cells to fight tumors, and produces HER-2 antibodies. "Our primary purpose is to check the safety of the vaccine, but we also want to make a preliminary assessment of the vaccine's ability to boost the immune system," Leach told Reuters.
- HER-2 is also present in normal tissues, so the immune system does not always respond to it. The vaccine's self-restoration is to enable the immune system to recognize HER-2 in cancer cells and destroy them, but let go of normal tissues. "It's clear that immunotherapy works," Leach said, which is within the scope of the potential to destroy tumors.
Breast cancer vaccine synthetic polysaccharide vaccine
- Breast x-ray
- The world's first "breast cancer vaccine" developed by the research team of Taiwan's "Research Institute Dean" Weng Qihui in 2007 was the first to have a therapeutic effect in the world. Previous experiments have proven that it is 80% effective in treating end-stage patients. The US Food and Drug Administration (FDA) and the Taiwan Department of Health have agreed to conduct Phase II and Phase III human trials at the same time in the near future. Weng Qihui said that the first-stage human trials of breast cancer vaccines were more than 80% effective, that is, after the vaccine was administered to ten patients with breast cancer, they could effectively kill cancer cells. Two.
- Weng Qihui announced the results of this research, saying that this is the first cancer vaccine in the world to use "synthetic polysaccharides" as a pathogen, and it is also the first vaccine to treat breast cancer. If the vaccine can be successfully marketed in the future, in addition to benefiting patients, the profit will exceed 20 billion US dollars.
Breast cancer vaccine effect
- US researchers said in June 2010 that the breast cancer vaccine they developed worked in mouse experiments and successfully prevented breast cancer. Researchers plan human clinical trials of the vaccine to test the effects. The study was led by immunologist Vincent Tuy of the Cleveland Clinic Scholar Institute, and the results were published in the British journal Nature-Medical.
- The vaccine targets a protein found in most breast cancer cells. Researchers divided genetically-affected mice that were susceptible to breast cancer into two groups and injected one of them with the vaccine and the other as a control without injection. After a period of time, none of the vaccinated mice became ill, and the other group of mice developed breast cancer.
- "We believe that this vaccine can be used to prevent breast cancer in adult women in the same way that many vaccines can prevent children from getting sick," Tuy said. However, researchers also said that the effectiveness of the vaccine on humans remains to be tested And large-scale applications may take several years.